Investor Relations

We are a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders. We improve compliance, absorption, and more with our proprietary drug delivery technology.

Stock Information

NASDAQLPCN
$2.97
NASDAQLPCN
Open
$3.05
Change
-$0.09 (-2.94%)
Day's Range
$2.97 - $3.08
52-Week Range
$1.04 - $3.45
Volume
43.2K
Market Cap
$73.8M